Preventing the Transmission of American Trypanosomiasis and Its Spread into Non-endemic Countries

Overview

Journal Infect Dis Poverty

Publisher Biomed Central

Date 2015 Dec 31

PMID 26715535

Citations 24

Authors

Qin Liu

Xiao-Nong Zhou

Affiliations

Soon will be listed here.

Abstract

American trypanosomiasis, commonly known as Chagas disease, is caused by the flagellate protozoan parasite Trypanosoma cruzi. An estimated eight million people infected with T. cruzi currently reside in the endemic regions of Latin America. However, as the disease has now been imported into many non-endemic countries outside of Latin America, it has become a global health issue. We reviewed the transmission patterns and current status of disease spread pertaining to American trypanosomiasis at the global level, as well as recent advances in research. Based on an analysis of the gaps in American trypanosomiasis control, we put forward future research priorities that must be implemented to stop the global spread of the disease.

Citing Articles

Concomitant diagnosis of Trypanosoma cruzi and HIV in a patient with neurologic manifestations: A case report.

Molina Solano E, Mora Diaz M, Montoya Madriz S, Lizano Calvo M, Retana Moreira L Braz J Infect Dis. 2024; 28(6):104478.

PMID: 39549639 PMC: 11609539. DOI: 10.1016/j.bjid.2024.104478.

Disruption of multiple copies of the Prostaglandin F2alpha synthase gene affects oxidative stress response and infectivity in Trypanosoma cruzi.

Santi A, Ribeiro J, Reis-Cunha J, Burle-Caldas G, Santos I, Silva P PLoS Negl Trop Dis. 2022; 16(10):e0010845.

PMID: 36260546 PMC: 9581433. DOI: 10.1371/journal.pntd.0010845.

Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.

Abras A, Ballart C, Fernandez-Arevalo A, Pinazo M, Gascon J, Munoz C Clin Microbiol Rev. 2022; 35(2):e0015221.

PMID: 35239422 PMC: 9020358. DOI: 10.1128/cmr.00152-21.

Drug repurposing for Chagas disease: In vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action.

Trindade J, Geraldo Freire-de-Lima C, Corte-Real S, Decote-Ricardo D, de Lima M PLoS One. 2021; 16(10):e0258292.

PMID: 34679091 PMC: 8535186. DOI: 10.1371/journal.pone.0258292.

Modelling the Ecological Suitability of the Chagas Disease Vector - China.

Guo Y, Shi Y, Zhang Y, Li Y, Wang M, Liu Q China CDC Wkly. 2021; 3(35):736-740.

PMID: 34594980 PMC: 8408656. DOI: 10.46234/ccdcw2021.182.

References

Schofield C, Dias J . The Southern Cone Initiative against Chagas disease. Adv Parasitol. 1999; 42:1-27. DOI: 10.1016/s0065-308x(08)60147-5. View

. Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol. 2001; 17(8):372-6. DOI: 10.1016/s1471-4922(01)01952-3. View

Dias J, Silveira A, Schofield C . The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz. 2002; 97(5):603-12. DOI: 10.1590/s0074-02762002000500002. View

Schijman A, Altcheh J, Burgos J, Biancardi M, Bisio M, Levin M . Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. J Antimicrob Chemother. 2003; 52(3):441-9. DOI: 10.1093/jac/dkg338. View

Yamagata Y, Nakagawa J . Control of Chagas disease. Adv Parasitol. 2006; 61:129-65. DOI: 10.1016/S0065-308X(05)61004-4. View

Schofield C, Jannin J, Salvatella R . The future of Chagas disease control. Trends Parasitol. 2006; 22(12):583-8. DOI: 10.1016/j.pt.2006.09.011. View

Sosa-Estani S, Segura E . Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina. Curr Opin Infect Dis. 2006; 19(6):583-7. DOI: 10.1097/01.qco.0000247592.21295.a5. View

Riera C, Guarro A, Kassab H, Jorba J, Castro M, Angrill R . Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am J Trop Med Hyg. 2006; 75(6):1078-81. View

Bern C, Montgomery S, Katz L, Caglioti S, Stramer S . Chagas disease and the US blood supply. Curr Opin Infect Dis. 2008; 21(5):476-82. DOI: 10.1097/QCO.0b013e32830ef5b6. View

10.

Bern C, Montgomery S . An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009; 49(5):e52-4. DOI: 10.1086/605091. View

11.

Gascon J, Bern C, Pinazo M . Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2009; 115(1-2):22-7. DOI: 10.1016/j.actatropica.2009.07.019. View

12.

Moncayo A, Silveira A . Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz. 2009; 104 Suppl 1:17-30. DOI: 10.1590/s0074-02762009000900005. View

13.

Soeiro M, Dantas A, Daliry A, da Silva C, Batista D, de Souza E . Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies. Mem Inst Oswaldo Cruz. 2009; 104 Suppl 1:301-10. DOI: 10.1590/s0074-02762009000900040. View

14.

Kinoshita-Yanaga A, Toledo M, Araujo S, Vier B, Gomes M . Accidental infection by Trypanosoma cruzi follow-up by the polymerase chain reaction: case report. Rev Inst Med Trop Sao Paulo. 2009; 51(5):295-8. DOI: 10.1590/s0036-46652009000500011. View

15.

Schmunis G, Yadon Z . Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2009; 115(1-2):14-21. DOI: 10.1016/j.actatropica.2009.11.003. View

16.

Isselbacher E, Kligerman S, Lam K, Hurtado R . Case records of the Massachusetts General Hospital. Case 2-2010. A 47-year-old man with abdominal and flank pain. N Engl J Med. 2010; 362(3):254-62. DOI: 10.1056/NEJMcpc0905548. View

17.

Silva J, Guedes P, Zottis A, Balliano T, Nascimento Silva F, Lopes L . Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity. Br J Pharmacol. 2010; 160(2):260-9. PMC: 2874849. DOI: 10.1111/j.1476-5381.2009.00524.x. View

18.

Alarcon De Noya B, Diaz-Bello Z, Colmenares C, Ruiz-Guevara R, Mauriello L, Zavala-Jaspe R . Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J Infect Dis. 2010; 201(9):1308-15. DOI: 10.1086/651608. View

19.

Coura J, Albajar Vinas P . Chagas disease: a new worldwide challenge. Nature. 2010; 465(7301):S6-7. DOI: 10.1038/nature09221. View

20.

Soeiro M, de Castro S . Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies. Open Med Chem J. 2011; 5:21-30. PMC: 3103897. DOI: 10.2174/1874104501105010021. View